Specifically, the team tested whether mRNA technology could be used to protect against the damage inflicted by the venom of ...

KAIST researchers have developed a method that attaches DNA fragments to mRNA to slow the onset of protein production, ...

The mRNA technology that helped end the COVID-19 pandemic may now hold the key to defeating cancer, and it exists because of ...

mRNA, widely known from the COVID-19 vaccine, is not actually a "therapeutic agent," but a technology that delivers the ...

RNA, widely known from the COVID-19 vaccine, is not actually a “therapeutic agent,” but a technology that delivers the ...

TriLink BioTechnologies senior scientist Dr Cody Palumbo discusses the blockers to manufacturing mRNA-based gene editing ...

Penn Medicine shows how sustained research investment drives innovation, economic growth, and global health breakthroughs.

The 5th mRNA-Based Therapeutics Summit Europe is the leading European industry-focused forum dedicated to accelerating the ...

Chennai, Dec. 5 -- Highlights: ...

The Department of Health and Human Services recently canceled $500 million in funding for vaccine research that it had previously pledged to scientists.

Pfizer's mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 trial, researchers reported in the results of a clinical trial.

In the upside-down world of Health and Human Services Secretary Robert F. Kennedy Jr., vaccines are on the ropes.